HashiCorp, Inc. (HCP) Stock Competitors & Peer Comparison
See (HCP) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HCP | $34.78 | +0.00% | 7.1B | -57.97 | -$0.60 | N/A |
| MSFT | $373.75 | -1.49% | 2.7T | 21.89 | $16.78 | +0.95% |
| ORCL | $165.76 | -10.06% | 504.6B | 30.04 | $5.84 | +1.10% |
| PLTR | $116.52 | -9.30% | 274.4B | 134.27 | $0.89 | N/A |
| PANW | $288.93 | +0.40% | 195.2B | 249.04 | $1.15 | N/A |
| CRWD | $679.91 | -0.72% | 171.9B | -4824.57 | -$0.14 | N/A |
| FTNT | $146.51 | +1.23% | 106.5B | 56.35 | $2.58 | N/A |
| SNPS | $466.08 | +2.32% | 89B | 106.31 | $4.37 | N/A |
| NET | $225.27 | +0.54% | 77.6B | -874.24 | -$0.25 | N/A |
| VMW | $142.48 | -4.96% | 61.5B | 42.92 | $3.32 | N/A |
Stock Comparison
HCP vs MSFT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, MSFT has a market cap of 2.7T. Regarding current trading prices, HCP is priced at $34.78, while MSFT trades at $373.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas MSFT's P/E ratio is 21.89. In terms of profitability, HCP's ROE is -0.16%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to MSFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MSFT's competition here
HCP vs ORCL Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ORCL has a market cap of 504.6B. Regarding current trading prices, HCP is priced at $34.78, while ORCL trades at $165.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ORCL's P/E ratio is 30.04. In terms of profitability, HCP's ROE is -0.16%, compared to ORCL's ROE of +0.50%. Regarding short-term risk, HCP is less volatile compared to ORCL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ORCL's competition here
HCP vs PLTR Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PLTR has a market cap of 274.4B. Regarding current trading prices, HCP is priced at $34.78, while PLTR trades at $116.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PLTR's P/E ratio is 134.27. In terms of profitability, HCP's ROE is -0.16%, compared to PLTR's ROE of +0.32%. Regarding short-term risk, HCP is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLTR's competition here
HCP vs PANW Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PANW has a market cap of 195.2B. Regarding current trading prices, HCP is priced at $34.78, while PANW trades at $288.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PANW's P/E ratio is 249.04. In terms of profitability, HCP's ROE is -0.16%, compared to PANW's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to PANW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PANW's competition here
HCP vs CRWD Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWD has a market cap of 171.9B. Regarding current trading prices, HCP is priced at $34.78, while CRWD trades at $679.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CRWD's P/E ratio is -4824.57. In terms of profitability, HCP's ROE is -0.16%, compared to CRWD's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWD's competition here
HCP vs FTNT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FTNT has a market cap of 106.5B. Regarding current trading prices, HCP is priced at $34.78, while FTNT trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FTNT's P/E ratio is 56.35. In terms of profitability, HCP's ROE is -0.16%, compared to FTNT's ROE of +1.56%. Regarding short-term risk, HCP is less volatile compared to FTNT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FTNT's competition here
HCP vs SNPS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SNPS has a market cap of 89B. Regarding current trading prices, HCP is priced at $34.78, while SNPS trades at $466.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SNPS's P/E ratio is 106.31. In terms of profitability, HCP's ROE is -0.16%, compared to SNPS's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to SNPS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SNPS's competition here
HCP vs NET Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NET has a market cap of 77.6B. Regarding current trading prices, HCP is priced at $34.78, while NET trades at $225.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NET's P/E ratio is -874.24. In terms of profitability, HCP's ROE is -0.16%, compared to NET's ROE of -0.06%. Regarding short-term risk, HCP is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NET's competition here
HCP vs VMW Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, HCP is priced at $34.78, while VMW trades at $142.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas VMW's P/E ratio is 42.92. In terms of profitability, HCP's ROE is -0.16%, compared to VMW's ROE of +3.99%. Regarding short-term risk, HCP is less volatile compared to VMW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VMW's competition here
HCP vs CRWV Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWV has a market cap of 60.7B. Regarding current trading prices, HCP is priced at $34.78, while CRWV trades at $105.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CRWV's P/E ratio is -40.92. In terms of profitability, HCP's ROE is -0.16%, compared to CRWV's ROE of -0.40%. Regarding short-term risk, HCP is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWV's competition here
HCP vs SQ Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, HCP is priced at $34.78, while SQ trades at $83.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SQ's P/E ratio is 49.98. In terms of profitability, HCP's ROE is -0.16%, compared to SQ's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to SQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQ's competition here
HCP vs XYZ Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, XYZ has a market cap of 43.5B. Regarding current trading prices, HCP is priced at $34.78, while XYZ trades at $72.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas XYZ's P/E ratio is 57.09. In terms of profitability, HCP's ROE is -0.16%, compared to XYZ's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to XYZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check XYZ's competition here
HCP vs TWLO Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TWLO has a market cap of 27.9B. Regarding current trading prices, HCP is priced at $34.78, while TWLO trades at $185.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TWLO's P/E ratio is 282.50. In terms of profitability, HCP's ROE is -0.16%, compared to TWLO's ROE of +0.01%. Regarding short-term risk, HCP is less volatile compared to TWLO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TWLO's competition here
HCP vs NETE Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, HCP is priced at $34.78, while NETE trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NETE's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to NETE's ROE of +3.34%. Regarding short-term risk, HCP is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NETE's competition here
HCP vs SPLK Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, HCP is priced at $34.78, while SPLK trades at $156.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SPLK's P/E ratio is 103.22. In terms of profitability, HCP's ROE is -0.16%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, HCP is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SPLK's competition here
HCP vs MDB Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, MDB has a market cap of 25.7B. Regarding current trading prices, HCP is priced at $34.78, while MDB trades at $320.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas MDB's P/E ratio is -862.59. In terms of profitability, HCP's ROE is -0.16%, compared to MDB's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MDB's competition here
HCP vs AFRM Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AFRM has a market cap of 24.2B. Regarding current trading prices, HCP is priced at $34.78, while AFRM trades at $71.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AFRM's P/E ratio is 65.64. In terms of profitability, HCP's ROE is -0.16%, compared to AFRM's ROE of +0.11%. Regarding short-term risk, HCP is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AFRM's competition here
HCP vs CPAY Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CPAY has a market cap of 22.7B. Regarding current trading prices, HCP is priced at $34.78, while CPAY trades at $339.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CPAY's P/E ratio is 20.78. In terms of profitability, HCP's ROE is -0.16%, compared to CPAY's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to CPAY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CPAY's competition here
HCP vs VRSN Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, VRSN has a market cap of 22.5B. Regarding current trading prices, HCP is priced at $34.78, while VRSN trades at $248.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas VRSN's P/E ratio is 27.36. In terms of profitability, HCP's ROE is -0.16%, compared to VRSN's ROE of -0.40%. Regarding short-term risk, HCP is less volatile compared to VRSN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRSN's competition here
HCP vs FFIV Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FFIV has a market cap of 22.1B. Regarding current trading prices, HCP is priced at $34.78, while FFIV trades at $387.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FFIV's P/E ratio is 32.12. In terms of profitability, HCP's ROE is -0.16%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to FFIV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FFIV's competition here
HCP vs FLT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, HCP is priced at $34.78, while FLT trades at $303.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FLT's P/E ratio is 22.97. In terms of profitability, HCP's ROE is -0.16%, compared to FLT's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to FLT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FLT's competition here
HCP vs CYBR Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, HCP is priced at $34.78, while CYBR trades at $408.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CYBR's P/E ratio is -139.06. In terms of profitability, HCP's ROE is -0.16%, compared to CYBR's ROE of -0.06%. Regarding short-term risk, HCP is more volatile compared to CYBR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check CYBR's competition here
HCP vs ZS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ZS has a market cap of 20.1B. Regarding current trading prices, HCP is priced at $34.78, while ZS trades at $126.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ZS's P/E ratio is -263.96. In terms of profitability, HCP's ROE is -0.16%, compared to ZS's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZS's competition here
HCP vs OKTA Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, OKTA has a market cap of 19.3B. Regarding current trading prices, HCP is priced at $34.78, while OKTA trades at $118.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas OKTA's P/E ratio is 84.01. In terms of profitability, HCP's ROE is -0.16%, compared to OKTA's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check OKTA's competition here
HCP vs IOT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, IOT has a market cap of 18.3B. Regarding current trading prices, HCP is priced at $34.78, while IOT trades at $31.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas IOT's P/E ratio is 316.90. In terms of profitability, HCP's ROE is -0.16%, compared to IOT's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check IOT's competition here
HCP vs AKAM Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AKAM has a market cap of 17.6B. Regarding current trading prices, HCP is priced at $34.78, while AKAM trades at $120.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AKAM's P/E ratio is 40.79. In terms of profitability, HCP's ROE is -0.16%, compared to AKAM's ROE of +0.09%. Regarding short-term risk, HCP is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AKAM's competition here
HCP vs DOCN Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DOCN has a market cap of 17.4B. Regarding current trading prices, HCP is priced at $34.78, while DOCN trades at $155.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DOCN's P/E ratio is 72.65. In terms of profitability, HCP's ROE is -0.16%, compared to DOCN's ROE of +1.54%. Regarding short-term risk, HCP is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOCN's competition here
HCP vs KSPI Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, KSPI has a market cap of 16.1B. Regarding current trading prices, HCP is priced at $34.78, while KSPI trades at $83.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas KSPI's P/E ratio is 7.66. In terms of profitability, HCP's ROE is -0.16%, compared to KSPI's ROE of +0.44%. Regarding short-term risk, HCP is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KSPI's competition here
HCP vs RBRK Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RBRK has a market cap of 14.5B. Regarding current trading prices, HCP is priced at $34.78, while RBRK trades at $74.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RBRK's P/E ratio is -48.30. In terms of profitability, HCP's ROE is -0.16%, compared to RBRK's ROE of +0.55%. Regarding short-term risk, HCP is less volatile compared to RBRK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RBRK's competition here
HCP vs NLOK Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, HCP is priced at $34.78, while NLOK trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NLOK's P/E ratio is 15.15. In terms of profitability, HCP's ROE is -0.16%, compared to NLOK's ROE of +0.40%. Regarding short-term risk, HCP is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NLOK's competition here
HCP vs TOST Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TOST has a market cap of 14.1B. Regarding current trading prices, HCP is priced at $34.78, while TOST trades at $24.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TOST's P/E ratio is 36.19. In terms of profitability, HCP's ROE is -0.16%, compared to TOST's ROE of +0.21%. Regarding short-term risk, HCP is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TOST's competition here
HCP vs GEN Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GEN has a market cap of 13.9B. Regarding current trading prices, HCP is priced at $34.78, while GEN trades at $23.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GEN's P/E ratio is 14.66. In terms of profitability, HCP's ROE is -0.16%, compared to GEN's ROE of +0.40%. Regarding short-term risk, HCP is less volatile compared to GEN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GEN's competition here
HCP vs NTNX Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NTNX has a market cap of 12.6B. Regarding current trading prices, HCP is priced at $34.78, while NTNX trades at $48.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NTNX's P/E ratio is 49.06. In terms of profitability, HCP's ROE is -0.16%, compared to NTNX's ROE of -0.38%. Regarding short-term risk, HCP is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTNX's competition here
HCP vs CHKP Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CHKP has a market cap of 12.5B. Regarding current trading prices, HCP is priced at $34.78, while CHKP trades at $124.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CHKP's P/E ratio is 12.39. In terms of profitability, HCP's ROE is -0.16%, compared to CHKP's ROE of +0.36%. Regarding short-term risk, HCP is less volatile compared to CHKP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CHKP's competition here
HCP vs CFLT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, HCP is priced at $34.78, while CFLT trades at $30.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CFLT's P/E ratio is -36.03. In terms of profitability, HCP's ROE is -0.16%, compared to CFLT's ROE of -0.27%. Regarding short-term risk, HCP is more volatile compared to CFLT. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check CFLT's competition here
HCP vs GDDY Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GDDY has a market cap of 9.9B. Regarding current trading prices, HCP is priced at $34.78, while GDDY trades at $76.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GDDY's P/E ratio is 11.89. In terms of profitability, HCP's ROE is -0.16%, compared to GDDY's ROE of +3.67%. Regarding short-term risk, HCP is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GDDY's competition here
HCP vs ALTR Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while ALTR trades at $111.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ALTR's P/E ratio is 699.06. In terms of profitability, HCP's ROE is -0.16%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, HCP is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check ALTR's competition here
HCP vs PLAN Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while PLAN trades at $63.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PLAN's P/E ratio is -44.82. In terms of profitability, HCP's ROE is -0.16%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, HCP is less volatile compared to PLAN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLAN's competition here
HCP vs PAYP Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PAYP has a market cap of 9.3B. Regarding current trading prices, HCP is priced at $34.78, while PAYP trades at $14.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PAYP's P/E ratio is 12.36. In terms of profitability, HCP's ROE is -0.16%, compared to PAYP's ROE of +0.47%. Regarding short-term risk, HCP is less volatile compared to PAYP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAYP's competition here
HCP vs CORZZ Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZZ has a market cap of 9.3B. Regarding current trading prices, HCP is priced at $34.78, while CORZZ trades at $28.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CORZZ's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to CORZZ's ROE of +1.09%. Regarding short-term risk, HCP is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZZ's competition here
HCP vs CORZ Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZ has a market cap of 9.2B. Regarding current trading prices, HCP is priced at $34.78, while CORZ trades at $28.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CORZ's P/E ratio is -8.65. In terms of profitability, HCP's ROE is -0.16%, compared to CORZ's ROE of +1.09%. Regarding short-term risk, HCP is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZ's competition here
HCP vs CORZW Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZW has a market cap of 9.2B. Regarding current trading prices, HCP is priced at $34.78, while CORZW trades at $22.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CORZW's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to CORZW's ROE of +1.09%. Regarding short-term risk, HCP is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZW's competition here
HCP vs INFA Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, HCP is priced at $34.78, while INFA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas INFA's P/E ratio is 826.33. In terms of profitability, HCP's ROE is -0.16%, compared to INFA's ROE of +0.00%. Regarding short-term risk, HCP is more volatile compared to INFA. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check INFA's competition here
HCP vs SAIL Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SAIL has a market cap of 7.2B. Regarding current trading prices, HCP is priced at $34.78, while SAIL trades at $12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SAIL's P/E ratio is -50.52. In terms of profitability, HCP's ROE is -0.16%, compared to SAIL's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SAIL's competition here
HCP vs KLAR Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, KLAR has a market cap of 6.8B. Regarding current trading prices, HCP is priced at $34.78, while KLAR trades at $17.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas KLAR's P/E ratio is -34.60. In terms of profitability, HCP's ROE is -0.16%, compared to KLAR's ROE of -0.08%. Regarding short-term risk, HCP is less volatile compared to KLAR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KLAR's competition here
HCP vs JCOM Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, HCP is priced at $34.78, while JCOM trades at $142.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas JCOM's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to JCOM's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check JCOM's competition here
HCP vs DBX Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DBX has a market cap of 6.6B. Regarding current trading prices, HCP is priced at $34.78, while DBX trades at $26.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DBX's P/E ratio is 14.10. In terms of profitability, HCP's ROE is -0.16%, compared to DBX's ROE of -0.28%. Regarding short-term risk, HCP is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DBX's competition here
HCP vs SQSP Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, HCP is priced at $34.78, while SQSP trades at $46.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, HCP's ROE is -0.16%, compared to SQSP's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to SQSP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQSP's competition here
HCP vs NEWR Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, HCP is priced at $34.78, while NEWR trades at $86.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NEWR's P/E ratio is -41.62. In terms of profitability, HCP's ROE is -0.16%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, HCP is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NEWR's competition here
HCP vs CCCS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, HCP is priced at $34.78, while CCCS trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CCCS's P/E ratio is -875.00. In terms of profitability, HCP's ROE is -0.16%, compared to CCCS's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CCCS's competition here
HCP vs DOX Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DOX has a market cap of 5.6B. Regarding current trading prices, HCP is priced at $34.78, while DOX trades at $53.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DOX's P/E ratio is 10.32. In terms of profitability, HCP's ROE is -0.16%, compared to DOX's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to DOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOX's competition here
HCP vs PATH Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PATH has a market cap of 5.4B. Regarding current trading prices, HCP is priced at $34.78, while PATH trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PATH's P/E ratio is 16.92. In terms of profitability, HCP's ROE is -0.16%, compared to PATH's ROE of +0.17%. Regarding short-term risk, HCP is less volatile compared to PATH. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PATH's competition here
HCP vs BB Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BB has a market cap of 5.2B. Regarding current trading prices, HCP is priced at $34.78, while BB trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BB's P/E ratio is 97.72. In terms of profitability, HCP's ROE is -0.16%, compared to BB's ROE of +0.07%. Regarding short-term risk, HCP is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BB's competition here
HCP vs S Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, S has a market cap of 5B. Regarding current trading prices, HCP is priced at $34.78, while S trades at $15.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas S's P/E ratio is -15.21. In terms of profitability, HCP's ROE is -0.16%, compared to S's ROE of -0.21%. Regarding short-term risk, HCP is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check S's competition here
HCP vs NVEI Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, HCP is priced at $34.78, while NVEI trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NVEI's P/E ratio is 212.44. In terms of profitability, HCP's ROE is -0.16%, compared to NVEI's ROE of -0.00%. Regarding short-term risk, HCP is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NVEI's competition here
HCP vs WEX Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, WEX has a market cap of 4.5B. Regarding current trading prices, HCP is priced at $34.78, while WEX trades at $128.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas WEX's P/E ratio is 14.65. In terms of profitability, HCP's ROE is -0.16%, compared to WEX's ROE of +0.27%. Regarding short-term risk, HCP is less volatile compared to WEX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WEX's competition here
HCP vs ACIW Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ACIW has a market cap of 4.4B. Regarding current trading prices, HCP is priced at $34.78, while ACIW trades at $44.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ACIW's P/E ratio is 21.68. In terms of profitability, HCP's ROE is -0.16%, compared to ACIW's ROE of +0.14%. Regarding short-term risk, HCP is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ACIW's competition here
HCP vs RELY Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RELY has a market cap of 4.4B. Regarding current trading prices, HCP is priced at $34.78, while RELY trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RELY's P/E ratio is 43.04. In terms of profitability, HCP's ROE is -0.16%, compared to RELY's ROE of +0.13%. Regarding short-term risk, HCP is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RELY's competition here
HCP vs ESMT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while ESMT trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ESMT's P/E ratio is 153.67. In terms of profitability, HCP's ROE is -0.16%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to ESMT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ESMT's competition here
HCP vs KVYO Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, KVYO has a market cap of 3.8B. Regarding current trading prices, HCP is priced at $34.78, while KVYO trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas KVYO's P/E ratio is -428.67. In terms of profitability, HCP's ROE is -0.16%, compared to KVYO's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KVYO's competition here
HCP vs VRNS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, VRNS has a market cap of 3.8B. Regarding current trading prices, HCP is priced at $34.78, while VRNS trades at $35.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas VRNS's P/E ratio is -28.95. In terms of profitability, HCP's ROE is -0.16%, compared to VRNS's ROE of -0.26%. Regarding short-term risk, HCP is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRNS's competition here
HCP vs QLYS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, QLYS has a market cap of 3.8B. Regarding current trading prices, HCP is priced at $34.78, while QLYS trades at $112.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas QLYS's P/E ratio is 19.48. In terms of profitability, HCP's ROE is -0.16%, compared to QLYS's ROE of +0.37%. Regarding short-term risk, HCP is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check QLYS's competition here
HCP vs BLSH Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BLSH has a market cap of 3.8B. Regarding current trading prices, HCP is priced at $34.78, while BLSH trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BLSH's P/E ratio is -3.35. In terms of profitability, HCP's ROE is -0.16%, compared to BLSH's ROE of -0.33%. Regarding short-term risk, HCP is less volatile compared to BLSH. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BLSH's competition here
HCP vs DLO Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DLO has a market cap of 3.6B. Regarding current trading prices, HCP is priced at $34.78, while DLO trades at $12.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DLO's P/E ratio is 19.08. In terms of profitability, HCP's ROE is -0.16%, compared to DLO's ROE of +0.37%. Regarding short-term risk, HCP is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DLO's competition here
HCP vs FOUR Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FOUR has a market cap of 3.5B. Regarding current trading prices, HCP is priced at $34.78, while FOUR trades at $38.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FOUR's P/E ratio is 44.31. In terms of profitability, HCP's ROE is -0.16%, compared to FOUR's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FOUR's competition here
HCP vs SWI Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, HCP is priced at $34.78, while SWI trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SWI's P/E ratio is 28.89. In terms of profitability, HCP's ROE is -0.16%, compared to SWI's ROE of +0.08%. Regarding short-term risk, HCP is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SWI's competition here
HCP vs CLBT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CLBT has a market cap of 3.1B. Regarding current trading prices, HCP is priced at $34.78, while CLBT trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CLBT's P/E ratio is 44.36. In terms of profitability, HCP's ROE is -0.16%, compared to CLBT's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CLBT's competition here
HCP vs EVOP Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, HCP is priced at $34.78, while EVOP trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EVOP's P/E ratio is -309.00. In terms of profitability, HCP's ROE is -0.16%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to EVOP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVOP's competition here
HCP vs TENB Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TENB has a market cap of 2.9B. Regarding current trading prices, HCP is priced at $34.78, while TENB trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TENB's P/E ratio is -263.40. In terms of profitability, HCP's ROE is -0.16%, compared to TENB's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TENB's competition here
HCP vs NTCT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NTCT has a market cap of 2.9B. Regarding current trading prices, HCP is priced at $34.78, while NTCT trades at $40.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NTCT's P/E ratio is 31.04. In terms of profitability, HCP's ROE is -0.16%, compared to NTCT's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTCT's competition here
HCP vs TDC Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TDC has a market cap of 2.8B. Regarding current trading prices, HCP is priced at $34.78, while TDC trades at $30.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TDC's P/E ratio is 6.80. In terms of profitability, HCP's ROE is -0.16%, compared to TDC's ROE of +1.42%. Regarding short-term risk, HCP is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TDC's competition here
HCP vs STNE Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, STNE has a market cap of 2.6B. Regarding current trading prices, HCP is priced at $34.78, while STNE trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas STNE's P/E ratio is 3.96. In terms of profitability, HCP's ROE is -0.16%, compared to STNE's ROE of +0.29%. Regarding short-term risk, HCP is less volatile compared to STNE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STNE's competition here
HCP vs PAGS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PAGS has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while PAGS trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PAGS's P/E ratio is 6.16. In terms of profitability, HCP's ROE is -0.16%, compared to PAGS's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to PAGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAGS's competition here
HCP vs CCC Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CCC has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while CCC trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CCC's P/E ratio is 71.50. In terms of profitability, HCP's ROE is -0.16%, compared to CCC's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to CCC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CCC's competition here
HCP vs ATEN Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ATEN has a market cap of 2.4B. Regarding current trading prices, HCP is priced at $34.78, while ATEN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ATEN's P/E ratio is 55.36. In terms of profitability, HCP's ROE is -0.16%, compared to ATEN's ROE of +0.21%. Regarding short-term risk, HCP is less volatile compared to ATEN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ATEN's competition here
HCP vs EEFT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EEFT has a market cap of 2.4B. Regarding current trading prices, HCP is priced at $34.78, while EEFT trades at $63.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EEFT's P/E ratio is 9.34. In terms of profitability, HCP's ROE is -0.16%, compared to EEFT's ROE of +0.24%. Regarding short-term risk, HCP is less volatile compared to EEFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EEFT's competition here
HCP vs PAYO Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PAYO has a market cap of 2.4B. Regarding current trading prices, HCP is priced at $34.78, while PAYO trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PAYO's P/E ratio is 35.10. In terms of profitability, HCP's ROE is -0.16%, compared to PAYO's ROE of +0.10%. Regarding short-term risk, HCP is less volatile compared to PAYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAYO's competition here
HCP vs WIX Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, WIX has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while WIX trades at $41.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas WIX's P/E ratio is -58.14. In terms of profitability, HCP's ROE is -0.16%, compared to WIX's ROE of +0.19%. Regarding short-term risk, HCP is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WIX's competition here
HCP vs CSGS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while CSGS trades at $80.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CSGS's P/E ratio is 36.02. In terms of profitability, HCP's ROE is -0.16%, compared to CSGS's ROE of +0.22%. Regarding short-term risk, HCP is more volatile compared to CSGS. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check CSGS's competition here
HCP vs RAMP Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RAMP has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while RAMP trades at $37.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RAMP's P/E ratio is 16.87. In terms of profitability, HCP's ROE is -0.16%, compared to RAMP's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to RAMP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RAMP's competition here
HCP vs AVPT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AVPT has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while AVPT trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AVPT's P/E ratio is 49.85. In terms of profitability, HCP's ROE is -0.16%, compared to AVPT's ROE of +0.10%. Regarding short-term risk, HCP is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AVPT's competition here
HCP vs AVDX Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while AVDX trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AVDX's P/E ratio is -250.00. In terms of profitability, HCP's ROE is -0.16%, compared to AVDX's ROE of -0.02%. Regarding short-term risk, HCP is more volatile compared to AVDX. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check AVDX's competition here
HCP vs GETVV Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while GETVV trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GETVV's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to GETVV's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GETVV's competition here
HCP vs SPSC Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SPSC has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while SPSC trades at $54.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SPSC's P/E ratio is 22.76. In terms of profitability, HCP's ROE is -0.16%, compared to SPSC's ROE of +0.09%. Regarding short-term risk, HCP is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SPSC's competition here
HCP vs FORG Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while FORG trades at $23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FORG's P/E ratio is -22.53. In terms of profitability, HCP's ROE is -0.16%, compared to FORG's ROE of -0.20%. Regarding short-term risk, HCP is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FORG's competition here
HCP vs GSKY Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while GSKY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GSKY's P/E ratio is 18.61. In terms of profitability, HCP's ROE is -0.16%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, HCP is less volatile compared to GSKY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GSKY's competition here
HCP vs WRD Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, WRD has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while WRD trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas WRD's P/E ratio is -7.93. In terms of profitability, HCP's ROE is -0.16%, compared to WRD's ROE of -0.24%. Regarding short-term risk, HCP is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WRD's competition here
HCP vs GET Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while GET trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GET's P/E ratio is 31.33. In terms of profitability, HCP's ROE is -0.16%, compared to GET's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GET's competition here
HCP vs RXT Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RXT has a market cap of 1.7B. Regarding current trading prices, HCP is priced at $34.78, while RXT trades at $6.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RXT's P/E ratio is -11.20. In terms of profitability, HCP's ROE is -0.16%, compared to RXT's ROE of +0.12%. Regarding short-term risk, HCP is less volatile compared to RXT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RXT's competition here
HCP vs STER Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while STER trades at $16.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas STER's P/E ratio is -98.47. In terms of profitability, HCP's ROE is -0.16%, compared to STER's ROE of -0.00%. Regarding short-term risk, HCP is less volatile compared to STER. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STER's competition here
HCP vs BAND Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BAND has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while BAND trades at $52.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BAND's P/E ratio is -133.74. In terms of profitability, HCP's ROE is -0.16%, compared to BAND's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to BAND. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BAND's competition here
HCP vs MQ Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, MQ has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while MQ trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas MQ's P/E ratio is 376.00. In terms of profitability, HCP's ROE is -0.16%, compared to MQ's ROE of +0.00%. Regarding short-term risk, HCP is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MQ's competition here
HCP vs EVTC Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EVTC has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while EVTC trades at $25.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EVTC's P/E ratio is 12.13. In terms of profitability, HCP's ROE is -0.16%, compared to EVTC's ROE of +0.21%. Regarding short-term risk, HCP is less volatile compared to EVTC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVTC's competition here
HCP vs EVCM Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EVCM has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while EVCM trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EVCM's P/E ratio is 67.00. In terms of profitability, HCP's ROE is -0.16%, compared to EVCM's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVCM's competition here
HCP vs ZUO Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while ZUO trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ZUO's P/E ratio is -19.65. In terms of profitability, HCP's ROE is -0.16%, compared to ZUO's ROE of -0.44%. Regarding short-term risk, HCP is less volatile compared to ZUO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZUO's competition here
HCP vs SUMO Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while SUMO trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SUMO's P/E ratio is -11.36. In terms of profitability, HCP's ROE is -0.16%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, HCP is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SUMO's competition here
HCP vs GB Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GB has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while GB trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GB's P/E ratio is 18.27. In terms of profitability, HCP's ROE is -0.16%, compared to GB's ROE of +0.35%. Regarding short-term risk, HCP is less volatile compared to GB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GB's competition here
HCP vs BASE Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BASE has a market cap of 1.4B. Regarding current trading prices, HCP is priced at $34.78, while BASE trades at $24.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BASE's P/E ratio is -17.38. In terms of profitability, HCP's ROE is -0.16%, compared to BASE's ROE of -0.45%. Regarding short-term risk, HCP is more volatile compared to BASE. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check BASE's competition here
HCP vs PICS Comparison June 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PICS has a market cap of 1.3B. Regarding current trading prices, HCP is priced at $34.78, while PICS trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PICS's P/E ratio is 5.71. In terms of profitability, HCP's ROE is -0.16%, compared to PICS's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to PICS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PICS's competition here